LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

Home・Akcijų sąrašas・NeoGenomics Inc

NeoGenomics Inc

Uždarymo kaina

10.87 -3.63

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

10.65

Max

11.3

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-7.2M -17M
Pardavimai	-3.5M 187M
Pelnas, tenkantis vienai akcijai	0.01
Pelno marža	-9.164
Darbuotojai	2,500
EBITDA	-5.8M -567K

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+32.01% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-07-28

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	239M 1.4B
Ankstesnė atidarymo kaina	14.5
Ankstesnė uždarymo kaina	10.87

NeoGenomics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-06-05 18:34; UTC

Rinkos pokalbiai

Hyperliquid ETFs Have Inflows Despite Crypto Weakness -- Market Talk

2026-06-05 16:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-06-05 15:16; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-06-05 15:16; UTC

Rinkos pokalbiai

Zcash Tumbles After Exploit Found -- Market Talk

2026-06-05 14:18; UTC

Rinkos pokalbiai

Bitcoin Breaks Streak of ETF Outflows -- Market Talk

2026-06-05 13:42; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-06-05 13:42; UTC

Rinkos pokalbiai

Zcash Sheds 31% as Cryptocurrency Plummets -- Market Talk

2026-06-05 07:12; UTC

Rinkos pokalbiai

Cryptocurrencies Fall Sharply as Selloff Continues -- Market Talk

2026-06-04 17:09; UTC

Rinkos pokalbiai

Retest of $55k Seen Possible for Bitcoin -- Market Talk

2026-06-04 16:46; UTC

Rinkos pokalbiai

Strategy BTC Sale Continues to Weigh on Prices -- Market Talk

2026-06-04 09:20; UTC

Rinkos pokalbiai

Ether Stays Under Pressure, Underpeforming Bitcoin -- Market Talk

2026-06-04 07:23; UTC

Rinkos pokalbiai

Bitcoin Remains Weak on Geopolitical Uncertainty, U.S. Rate-Rise Bets -- Market Talk

2026-06-04 03:02; UTC

Rinkos pokalbiai

Bitcoin Slips Amid Risk-Off Sentiment -- Market Talk

2026-06-03 18:24; UTC

Rinkos pokalbiai

New Bitcoin Support Level at $65k -- Market Talk

2026-06-03 17:21; UTC

Rinkos pokalbiai

Long Liquidations in Bitcoin Mount -- Market Talk

2026-06-03 14:52; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-06-03 14:52; UTC

Rinkos pokalbiai

Privacy Coins Gain Amid BTC Weakness -- Market Talk

2026-06-03 07:05; UTC

Rinkos pokalbiai

Bitcoin Falls After Fresh Attacks Between U.S. and Iran -- Market Talk

2026-06-02 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-06-02 16:26; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-06-02 16:25; UTC

Rinkos pokalbiai

Solana Plummets as Memecoin Appetite Fades -- Market Talk

2026-06-02 16:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-06-02 16:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-06-02 16:08; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-06-02 16:08; UTC

Rinkos pokalbiai

Bitcoin Out of Top 10 Assets as Downturn Deepens -- Market Talk

2026-06-02 14:12; UTC

Rinkos pokalbiai

Fear in Control of Crypto Market -- Market Talk

2026-06-02 14:10; UTC

Rinkos pokalbiai

Bitcoin Tumbles Below $70k on ETF Outflow -- Market Talk

2026-06-02 11:25; UTC

Rinkos pokalbiai

Bitcoin Stays Weak on Geopolitical Uncertainty, Strategy's Sale of Cryptocurrency -- Market Talk

2026-06-02 07:17; UTC

Rinkos pokalbiai

Bitcoin Extends Losses on Strategy Sale, Middle East Conflict -- Market Talk

2026-06-01 16:54; UTC

Rinkos pokalbiai

Correction to Hyperliquid Market Talk

Akcijų palyginimas

Kainos pokytis

NeoGenomics Inc Prognozė

Kainos tikslas

By TipRanks

32.01% į viršų

12 mėnesių prognozė

Vidutinis 14.93 USD 32.01%

Aukščiausias 25 USD

Žemiausias 11 USD

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines NeoGenomics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

10 ratings

Pirkti

Laikyti

Parduoti

Remiantis 10 analitikų, pateikusių NeoGenomics Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.